Last updated: 2026-09-15 00:40:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $266.35, with a market capitalization of $640.02B and a P/E ratio of 30.42. Over the past 52 weeks, its price has ranged from $173.33 to $281.07. This page covers its latest market performance, valuation, price trends and company information.
$640.02B | |
$271.00 | |
$281.07 | |
$46.25 | |
$265.58 | |
2.78M | |
7.67M | |
30.42 | |
$281.07 | |
$173.33 | |
1.97% | |
-- |
Johnson & Johnson (JNJ) last closed at $265.58 as of 2026-09-15 00:00:00, unchanged from the previous close of $265.58.
During the latest regular trading session, JNJ traded between $46.25 and $281.07, with a volume of 2.78M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Johnson & Johnson (JNJ) moved from $275.21 to $266.35, representing a decline of 3.22% ($8.86).
The stock traded between $265.25 and $281.07 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 6.00 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 86.3%
JNJ is currently trading at $266.35, placing it 86.3% of the way from its 52-week low of $173.33 to its 52-week high of $281.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.